TICKERNERD
Menu
GLGLFinancial Services · Insurance - Life

GL Stock Forecast: Globe Life, Inc. Price Predictions for 2026-2027

Last close, 14 Aug 2026
$181
+0.18% on the day

The 11 Wall Street analysts covering Globe Life, Inc. hold a median 12-month price target of $192 — +6.1% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 73 of 100 as at 15 Aug 2026 — in the upper half. Here, the model and the Street point the same way.

Market cap
$14.1B
Ticker Nerd rank
73 / 100
Median analyst target
$192
Analysts covering
11
Total return, dividends reinvested
1W
−1.6%
1M
+1.1%
YTD
+30.2%
1Y
+31.7%
From 52W high
−2.7%
From 52W low
+39.7%
$130
$186
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

GL stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Globe Life, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 15 Aug 2026
73 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Momentum
95
Growth
80
Issuance
79
Revisions
74
Quality
68
Volatility
62
Value
42
Accruals
26
Size
13

Momentum (95): The shares have been drifting up relative to others.

Accruals (26): A large share of reported profit has not shown up as cash, or the balance sheet is expanding quickly — both tend to unwind.

Size (13): Larger than most of the companies we track — more scrutinised, less often mispriced.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

GL stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on GL, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$120$140$160$180$200$220$240Oct 25Jan 26Apr 26Jul 26GLHigh $225Median $192Low $166

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

What Wall Street says11 analysts
8 Buy3 Hold0 Sell
Low $166Median $192High $225

The green dot is the last close — the median target sits +6.1% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 8 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
24 July 2026Keefe, Bruyette & WoodsMaintainsOutperform$192 → $190
22 July 2026TD CowenMaintainsBuy$215 → $225
21 July 2026JP MorganMaintainsOverweight$181 → $201
15 July 2026Piper SandlerMaintainsOverweight$175 → $200
15 July 2026Piper SandlerMaintainsOverweight—
13 July 2026Evercore ISI GroupMaintainsIn-Line$157 → $176
13 July 2026Evercore ISI GroupMaintainsIn-Line—
13 July 2026Keefe, Bruyette & WoodsMaintainsOutperform$180 → $192
13 July 2026Keefe, Bruyette & WoodsMaintainsOutperform—
10 July 2026JefferiesMaintainsHold—
10 July 2026JefferiesMaintainsHold$147 → $166
9 July 2026Wells FargoMaintainsOverweight$172 → $193
9 July 2026Wells FargoMaintainsOverweight—
6 July 2026Morgan StanleyMaintainsOverweight$181 → $208
6 July 2026Morgan StanleyMaintainsOverweight—
23 June 2026TD CowenMaintainsBuy—
26 May 2026Piper SandlerMaintainsOverweight—
21 May 2026Morgan StanleyMaintainsOverweight—
24 Apr 2026Truist SecuritiesMaintainsBuy—
10 Apr 2026Wells FargoMaintainsOverweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. GL appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Estimates

GL analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+1.0%
Analysts raising
6
Analysts cutting
1
Fundamentals

Globe Life, Inc. (GL) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
12.0×

Cheaper than 55% of US stocks

Price / sales
2.3×

Cheaper than 50% of US stocks

Price / book
2.3×

Cheaper than 43% of US stocks

EV / EBITDA
10.0×

Cheaper than 39% of US stocks

Growth & margins
Revenue growth (YoY)
8.0%

Higher than 47% of US stocks

Earnings growth (YoY)
13.8%

Higher than 52% of US stocks

Gross margin
—
Operating margin
24.6%

Higher than 84% of US stocks

Net margin
19.6%

Higher than 82% of US stocks

Returns & dividend
Return on equity
20.9%

Higher than 82% of US stocks

Return on assets
3.4%

Higher than 67% of US stocks

Dividend yield
0.7%

Higher than 16% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Peers

GL vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelInsurance - Life
CompanyMarket capTKN rank
GLGlobe Life, Inc.$14.1B
73
UNMUnum Group$15.1B
51
PRIPrimerica, Inc.$9.7B
84
JXNJackson Financial, Inc.$9.2B
65
LNCLincoln National Corp.$8.7B
73
CNOCNO Financial Group, Inc.$5.1B
76
PRUPrudential Financial, Inc.$43.8B
74

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Globe Life, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest GL news & analysis

4 Accident & Health Insurers to Watch Amid Elevated Healthcare Costs

Zacks Investment Research · 11 Aug 2026neutral

Zacks Investment Research highlighted accident and health insurers including GL as set to benefit from rising underwriting exposure and digitalization, while noting pricing pressures from elevated medical costs and inflation.

Why it matters — The report identifies both growth drivers and headwinds for GL, giving investors a balanced view of the operating environment for accident and health insurers.

Globe Life Announces New Share Repurchase Authorization

PRNewsWire · 10 Aug 2026positive

Globe Life Inc. announced a new authorization, effective August 15, 2026, to repurchase up to $2.5 billion of common stock under its existing share repurchase program. The authorization was approved by the Board of Directors on August 5, 2026, and replaces previous authorizations.

Why it matters — A GL watcher would care because a new, larger repurchase authorization signals the board's confidence in the company's financial position and provides potential ongoing support for the stock.

GLOBE LIFE INC. DECLARES DIVIDEND

PRNewsWire · 6 Aug 2026neutral

Globe Life Inc. announced that its Board of Directors declared a quarterly dividend of $0.33 per share on its outstanding common stock. The dividend is payable on October 30, 2026, to shareholders of record as of the close of business on October 5, 2026.

Why it matters — A GL watcher would note that the company continues its consistent quarterly dividend program for shareholders.

FAQ

Frequently asked questions about GL stock

What is the GL stock price forecast for 2026-2027?

The 11 Wall Street analysts covering Globe Life, Inc. have a median 12-month price target of $192, with estimates ranging from $166 to $225. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is GL stock a buy right now?

Of the 11 analysts covering Globe Life, Inc., 8 rate it a Buy, 3 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Globe Life, Inc. 73 out of 100 across roughly 4,600 US stocks as at 15 Aug 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank GL?

As at 15 Aug 2026, Globe Life, Inc. ranks 73 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Momentum (95 of 100).

Will GL stock go up?

No one can know that. What the data says: the median 12-month target from 11 analysts implies +6.1% from the last close, and Ticker Nerd's factor model ranks Globe Life, Inc. 73 out of 100 as at 15 Aug 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the GL stock forecast for 2030?

No analyst covering Globe Life, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for GL are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $166 to $225 over the next 12 months.

How has GL stock performed over the past year?

Globe Life, Inc. returned +31.7% over the 12 months to 14 Aug 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Globe Life, Inc. do?

Globe Life Inc. is an insurance holding company that provides a broad range of life and supplemental health insurance products, along with annuities, to individuals and families in the United States.

What is the latest news on GL?

The most recent item we track (Zacks Investment Research, 11 Aug 2026): "4 Accident & Health Insurers to Watch Amid Elevated Healthcare Costs". Zacks Investment Research highlighted accident and health insurers including GL as set to benefit from rising underwriting exposure and digitalization, while noting pricing pressures from elevated medical costs and inflation.

Company

About Globe Life, Inc.

Globe Life Inc. is an insurance holding company that provides a broad range of life and supplemental health insurance products, along with annuities, to individuals and families in the United States. Headquartered in McKinney, Texas, the company operates through core segments that include life insurance, supplemental health insurance, and investments. Its life insurance offerings span traditional whole life, interest-sensitive whole life, and term life policies designed to provide financial protection and coverage flexibility. In health insurance, Globe Life focuses on guaranteed-renewable products such as Medicare supplement, critical illness, accident, and limited-benefit hospital and surgical coverage. The company also offers fixed-benefit annuity contracts aimed at supporting long-term financial planning needs. Globe Life distributes its products through multiple channels, including captive agencies, independent agents, and direct-to-consumer platforms, allowing it to reach a wide customer base across diverse income levels and geographies. Through its investment operations, the company manages a largely fixed-maturity portfolio structured to support policy obligations and maintain the stability of its insurance offerings in the broader financial services market.

CEO Mr. Frank Martin Svoboda · 3,695 employees · United States · https://home.globelifeinsurance.com